Active ingredientSertindoleCat. No. P-S036-001CAS 106516-24-9Family · Pharmaceutical analytical standards
Sertindole
An atypical antipsychotic of the phenylindole family, discovered in Denmark in 1985 and approved in Europe in 1996 for the treatment of schizophrenia. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It acts mainly on the limbic dopamine system and spares the striatal one, which is why movement side effects are uncommon; its half-life is about three days.
Go to the active ingredient →Active ingredientSertindoleCat. No. P-S036-001CAS 106516-24-9
Isotopically labelledSertindole-d4Cat. No. P-S036-002CAS 1794737-42-0
Impurity5-Chloro-1-(4-fluorophenyl)-1H-indoleCat. No. P-S036-003CAS 138900-22-8
ImpurityDehydrosertindoleCat. No. P-S036-004CAS 173294-84-3
ImpuritySertindole Impurity 1 AcetateCat. No. P-S036-005No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.